Final ID: LBP63
Wu Runda, Su Ya, Wang Wanxin, Dai Yuxiang, Hong Shangyu, Yao Kang, Ge Junbo, Zhang Shuning, Ma Yuanji, Gao Wei, Liao Jianquan, Weng Xinyu, Teng Yongduan, Zhang Lei, Xu Lili
Engineering and Development of Optimal CRISPR Based Genome Modification Molecules for Safe and Effective LDL-C LoweringDuncan-lewis Christopher, Colin Isabel, Corbo Lana, Deiter Fred, Demaree Benjamin, Denny Sarah, Fernandes Jason, Gardner Matthew, Hadaczek Piotr, Hochman Myles, Hsu Bernadette, Harms Matthew, Karanth Santhosh, Karmarkar Maitreyee, Keller Steven, Kozy Heather, Krupa Oleh, Leeman Dena, Li Yuexuan, Mirotsou Maria, Mok Amanda, Mrak Anna, Adil Maroof, Narsineni Lokesh, Ripley-phipps Sterling, Reimer Kirsten, Szulwach Keith, Shroff Shilpa, Tran Vanessa, Tung Kuei-ling, Wright Addison, Oakes Benjamin, Khakoo Aarif, Alcantra-lee Raniel, Bardai Farah, Oresic Bender Kristina, Bale Shyam Sundhar, Charles Emeric, Chen Kai-yuan
We encourage you to enter the discussion by posting your comments and questions below.
Presenters will be notified of your post so that they can respond as appropriate.
This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.
You have to be authorized to post a comment. Please, Login or Signup.